Avid Bioservices Inc (CDMO)

[InternetForumUser]

GEO: Another PR about enrollment status which is MEASURABLE. I think I could find many more but won't waste my time because IR won't change. They are the same IR which stated PPHM was "non-dilutive" financing.

One month into the study, the trial has completed enrollment of approximately 20 percent of the total patients scheduled in the protocol.

http://cellceutix.com/cellceutix-reports-20-percent-enrollment-completed-in-phase-2b-trial-of-brilacidin-as-short-course-therapy-for-absssi/#sthash.P3nrLF4b.dpbs